• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MOR:GR

75.480 EUR 0.990 1.33%

As of 13:55:06 ET on 09/19/2014.

Snapshot for MorphoSys AG (MOR)

Open: 74.840 Day's Range: 74.480 - 77.440 Volume: 327,600
Previous Close: 74.490 52wk Range: 50.240 - 78.400 1-Yr Rtn: +33.12%

Stock Chart for MOR

No chart data available.
  • MOR:GR 75.650
  • 1D
  • 1M
  • 1Y
74.490
Interactive MOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MOR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -0.2000
Est. EPS (EUR) (12/2014) -0.3790
Est. PEG Ratio -
Market Cap (M EUR) 1,991.06
Shares Outstanding (M) 26.38
30 Day Average Volume 75,224
Price/Book (mrq) 5.5971
Price/Sale (ttm) 31.9060
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MOR

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MOR

MorphoSys AG is a biotechnology company. The Company uses proprietary technology to develop human antibodies tailored to treat specific diseases. MorphoSys is developing medicines to treat cancer and inflammation.

Simon E MoroneyChairman-Mgmt Board/CEOJens HolsteinChief Financial Officer
Marlies SprollChief Scientific OfficerArndt SchotteliusChief Development Officer
More Company Profile & Key Executives for MOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil